2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine

Meletios A Dimopoulos; D. Weber; Hagop M. Kantarjian; Michael J. Keating; Raymond Alexanian

doi:10.1093/oxfordjournals.annonc.a058811

Related publications

Article1993

Fludarabine therapy in Waldenström's macroglobulinemia

Meletios A Dimopoulos, Susan O’Brien, Hagop M. Kantarjian, Sherry Pierce, Kay Delasalle, B Barlogie, Raymond Alexanian, Michael J. Keating

Article2002

Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia

Meletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, George Hamilos, Dimitra Gika, Eleni Efstathiou, Panayiotis Panayiotidis, Elina Vervessou, Nikolaos Anagnostopoulos, John Christakis

Article2003

Treatment of Waldenstrom's Macroglobulinemia with the Combination of Fludarabine and Cyclophosphamide

Meletios A Dimopoulos, George Hamilos, Eleni Efstathiou, Ioannis Siapkaras, Charis Matsouka, Dimitra Gika, Vassiliki Grigoraki, Christos Papadimitriou, Dimitrios Mitsibounas, Nikolaos Anagnostopoulos

Article1994

Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.

Meletios A Dimopoulos, H. Kantarjian, D. Weber, S O'brien, E Estey, Kay Delasalle, Esther Rose, Fernando Cabanillas, M Keating, Raymond Alexanian

Letter2016

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström’s macroglobulinemia

Maria Gavriatopoulou, Efstathios Kastritis, Marie‐Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Μαρία Ρούσσου, Despina Fotiou, Magdalini Migkou, Maria Mpakiri, Anna Tasidou, Evangelos Terpos, Meletios A Dimopoulos